Foundations Investment Advisors LLC Buys 214 Shares of Stryker Co. (NYSE:SYK)

Foundations Investment Advisors LLC lifted its position in Stryker Co. (NYSE:SYK) by 12.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,967 shares of the medical technology company’s stock after acquiring an additional 214 shares during the period. Foundations Investment Advisors LLC’s holdings in Stryker were worth $708,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in SYK. Parnassus Investments LLC purchased a new stake in shares of Stryker during the 3rd quarter valued at about $762,798,000. International Assets Investment Management LLC increased its holdings in Stryker by 66,967.5% in the 3rd quarter. International Assets Investment Management LLC now owns 853,769 shares of the medical technology company’s stock worth $308,433,000 after acquiring an additional 852,496 shares in the last quarter. RTW Investments LP purchased a new stake in shares of Stryker in the third quarter worth $143,392,000. State Street Corp lifted its stake in shares of Stryker by 2.2% during the 3rd quarter. State Street Corp now owns 14,582,959 shares of the medical technology company’s stock valued at $5,279,788,000 after buying an additional 316,404 shares in the last quarter. Finally, FMR LLC boosted its holdings in Stryker by 3.0% in the 3rd quarter. FMR LLC now owns 7,306,994 shares of the medical technology company’s stock worth $2,639,725,000 after buying an additional 215,782 shares during the period. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Stryker

In related news, CEO Kevin Lobo sold 57,313 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $368.70, for a total value of $21,131,303.10. Following the completion of the transaction, the chief executive officer now owns 100,027 shares of the company’s stock, valued at $36,879,954.90. The trade was a 36.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 5.50% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. JMP Securities reissued a “market perform” rating on shares of Stryker in a report on Tuesday, January 7th. Needham & Company LLC reissued a “buy” rating and set a $442.00 target price on shares of Stryker in a research note on Wednesday. Canaccord Genuity Group upped their price target on Stryker from $420.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday. BTIG Research lifted their price objective on shares of Stryker from $383.00 to $394.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Finally, Evercore ISI increased their price objective on shares of Stryker from $380.00 to $384.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and a consensus target price of $413.45.

Stryker Stock Down 1.1 %

Shares of NYSE SYK opened at $390.98 on Thursday. Stryker Co. has a 1 year low of $314.05 and a 1 year high of $406.19. The firm has a 50-day simple moving average of $376.44 and a two-hundred day simple moving average of $361.98. The company has a market cap of $149.05 billion, a P/E ratio of 41.91, a PEG ratio of 2.68 and a beta of 0.95. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.91 and a quick ratio of 1.22.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.07% and a net margin of 16.34%. During the same quarter in the previous year, the company posted $3.46 earnings per share. Research analysts anticipate that Stryker Co. will post 12.06 earnings per share for the current year.

Stryker Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.86%. This is a boost from Stryker’s previous quarterly dividend of $0.80. The ex-dividend date of this dividend is Tuesday, December 31st. Stryker’s payout ratio is 36.01%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.